Demographic and clinical data (mean values) for patients with MGUS and multiple myeloma in this study
. | MGUS, n = 14 . | Multiple myeloma, n = 44 . | |
|---|---|---|---|
| Age | 64 y, 2 mo ± 5 y, 1 mo59 y, 10 mo ± 4, y 4 mo | ||
| M/F ratio | 0.87:1 | 1.5:1 | |
| Hemoglobin level, g/dL | 12.8 ± 0.1 | 10.5 ± 0.1 | |
| Serum creatinine level, mg/dL | 1.0 ± 0.1 | 1.6 ± 0.1 | |
| Serum albumin level, g/dL | 3.9 ± 0.1 | 3.2 ± 0.1 | |
| β2-microglobulin level, mg/L | 2.0 ± 0.1 | 4.2 ± 0.2 | |
| C-reactive protein level, mg/dL | 1.8 ± 0.2 | 1.3 ± 0.1 | |
| Heavy chain isotype (%) | |||
| IgA | 2 (14) | 13 (30) | |
| IgG | 11 (79) | 22 (50) | |
| IgM | 1 (7) | 2 (4.5) | |
| IgD | NA | 1 (2) | |
| IgA + IgG | NA | 1 (2) | |
| Light chain | NA | 3 (7) | |
| Oligosecretory | NA | 2 (4.5) | |
| Light chain isotype | |||
| Kappa | 9 | 34 | |
| Lambda | 5 | 10 | |
| Stage | |||
| I | NA | 3 | |
| II | NA | 3 | |
| III | NA | 38 | |
. | MGUS, n = 14 . | Multiple myeloma, n = 44 . | |
|---|---|---|---|
| Age | 64 y, 2 mo ± 5 y, 1 mo59 y, 10 mo ± 4, y 4 mo | ||
| M/F ratio | 0.87:1 | 1.5:1 | |
| Hemoglobin level, g/dL | 12.8 ± 0.1 | 10.5 ± 0.1 | |
| Serum creatinine level, mg/dL | 1.0 ± 0.1 | 1.6 ± 0.1 | |
| Serum albumin level, g/dL | 3.9 ± 0.1 | 3.2 ± 0.1 | |
| β2-microglobulin level, mg/L | 2.0 ± 0.1 | 4.2 ± 0.2 | |
| C-reactive protein level, mg/dL | 1.8 ± 0.2 | 1.3 ± 0.1 | |
| Heavy chain isotype (%) | |||
| IgA | 2 (14) | 13 (30) | |
| IgG | 11 (79) | 22 (50) | |
| IgM | 1 (7) | 2 (4.5) | |
| IgD | NA | 1 (2) | |
| IgA + IgG | NA | 1 (2) | |
| Light chain | NA | 3 (7) | |
| Oligosecretory | NA | 2 (4.5) | |
| Light chain isotype | |||
| Kappa | 9 | 34 | |
| Lambda | 5 | 10 | |
| Stage | |||
| I | NA | 3 | |
| II | NA | 3 | |
| III | NA | 38 | |
NA indicates not applicable.